Provided by Tiger Fintech (Singapore) Pte. Ltd.

Karyopharm Therapeutics

3.85
-0.2200-5.41%
Post-market: 4.100.2500+6.49%18:03 EDT
Volume:151.97K
Turnover:613.20K
Market Cap:33.26M
PE:-0.31
High:4.17
Open:4.09
Low:3.85
Close:4.07
Loading ...

HC Wainwright Downgrades Karyopharm Therapeutics to Neutral From Buy

MT Newswires Live
·
16 Jul

Karyopharm Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
16 Jul

Karyopharm Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
16 Jul

BUZZ-U.S. STOCKS ON THE MOVE-AeroVironment, Civista Bancshares, Meta

Reuters
·
12 Jul

Karyopharm Therapeutics Shares Down 16.4% Premarket After Co Announces Job Cuts

THOMSON REUTERS
·
11 Jul

Karyopharm to Cut About 20% of Workforce Amid Ongoing Review

Dow Jones
·
11 Jul

Karyopharm Therapeutics Explores Financing and Strategic Options

TIPRANKS
·
11 Jul

BRIEF-Karyopharm Therapeutics Inc Reducing Workforce By About 20%

Reuters
·
11 Jul

Karyopharm Therapeutics Inc - Reducing Workforce by About 20% - SEC Filing

THOMSON REUTERS
·
11 Jul

Karyopharm Therapeutics Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $27

THOMSON REUTERS
·
11 Jul

Karyopharm Therapeutics Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
11 Jul

Karyopharm assumed with a Buy at H.C. Wainwright

TIPRANKS
·
11 Jul

Karyopharm Therapeutics Announces New Inducement Grants for Newly-Hired Employees Under Stock Incentive Plan

Reuters
·
02 Jul

Karyopharm Therapeutics Inc. Publishes Presentation on Myelofibrosis Treatment and Selinexor's Potential in Cancer Therapy

Reuters
·
05 Jun

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
03 Jun

Karyopharm Therapeutics Announces New Inducement Stock Incentive Plan with RSU Awards for New Employees

Reuters
·
03 Jun

Karyopharm Therapeutics Inc. Concluded Annual Stockholders Meeting

Reuters
·
30 May

Karyopharm Therapeutics Inc. to Participate in RBC Capital Markets Global Healthcare Conference

Reuters
·
19 May

Karyopharm abstract selected for presentation at 2025 EHA meeting

TIPRANKS
·
14 May

These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results

Benzinga
·
14 May